Home › Funds › Baugh & Associates, LLC › ABBV

Baugh & Associates, LLC position in ABBV

ABBVIE INC · Health Care

Baugh & Associates, LLC reported holding 40,501 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$9.5M, representing 4.28% of its reported portfolio and ranking #5 among its reported holdings. Baugh & Associates, LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)40.50K sh
Reported value held$9.45M
Portfolio Weight4.28%
First reportedQ3 2023
Last changeAdd
Updated2026-10-16

Last updated: 2026-10-16 · Source: SEC EDGAR Form 13F-HR

How Baugh & Associates, LLC's ABBV position evolved

Baugh & Associates, LLC first disclosed a stake in ABBV in Q3 2023 at 46,875 shares (US$7.0M). The position peaked in Q3 2026 at 40,501 shares, worth US$9.5M. Across 13 filings, Baugh & Associates, LLC increased the stake 3 time(s), trimmed it 6 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 40,501 shares valued at US$9.5M — an increase of 3,007 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 46.88K $6.99M New
Q4 2023 46.24K $7.17M Reduce
Q1 2024 46.21K $8.41M Hold
Q2 2024 43.97K $7.90M Reduce
Q3 2024 44.36K $8.53M Add
Q4 2024 45.18K $7.77M Add
Q1 2025 44.96K $9.06M Hold
Q2 2025 42.74K $7.35M Reduce
Q3 2025 41.76K $8.91M Reduce
Q4 2025 40.51K $8.65M Reduce
Q1 2026 40.33K $8.77M Hold
Q2 2026 37.49K $9.43M Reduce
Q3 2026 40.50K $9.45M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 35 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Baugh & Associates, LLC held ABBV?

Baugh & Associates, LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Baugh & Associates, LLC's current position in ABBV?

As of Q3 2026, Baugh & Associates, LLC holds 40.50K shares of ABBV (ABBVIE INC), valued at $9.45M, representing 4.28% of its reported portfolio and ranking #5.

Has Baugh & Associates, LLC been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Baugh & Associates, LLC increased its position in ABBV. The position peaked in Q3 2026 at 40.50K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.